مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

150
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

101
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

Intravenous Thrombolysis for Stroke in Patients Receiving Oral Factor Xa Inhibitors

Pages

  0-0

Abstract

 We present 3 patients who were taking oral direct Factor Xa Inhibitors (ODFXIs) within 24 hours prior to receiving intravenous recombinant tissue plasminogen activator (IV rtPA) for acute ischemic Stroke (AIS). Two patients were on Rivaroxaban (20 mg once daily) and one on Apixaban (2. 5mgtwice daily). All 3 received IV rtPA within 3 hours of symptom onset. Their aPPT, PT and INR levels were within normal ranges. They all received the last dose of the ODFXI within the last 24 hours prior to IV rtPA administration. One patient underwent mechanical thrombectomy of a large vessel clot after IV rtPA. None had intracranial hemorrhage (ICH) on 24 hour head CT post IV rtPA. They all had acute infarcts on their brain MRI, diffusion weighted image. Although we had a very low number of patients in our case series, our findings suggest that neither IV rtPA nor the combination of IV rtPA and intra-arterial thrombolysis increases the risk of ICH in AIS patients who are taking ODFXIs and their coagulation parameters are within normal range.

Cites

  • No record.
  • References

    Cite

    APA: Copy

    MOWLA, ASHKAN, Lail, Navdeep S., Vaughn, Caila B., Kamal, Haris, Sawyer, Robert N., & Deline, Christopher. (2018). Intravenous Thrombolysis for Stroke in Patients Receiving Oral Factor Xa Inhibitors. ARCHIVES OF NEUROSCIENCE, 5(4), 0-0. SID. https://sid.ir/paper/354669/en

    Vancouver: Copy

    MOWLA ASHKAN, Lail Navdeep S., Vaughn Caila B., Kamal Haris, Sawyer Robert N., Deline Christopher. Intravenous Thrombolysis for Stroke in Patients Receiving Oral Factor Xa Inhibitors. ARCHIVES OF NEUROSCIENCE[Internet]. 2018;5(4):0-0. Available from: https://sid.ir/paper/354669/en

    IEEE: Copy

    ASHKAN MOWLA, Navdeep S. Lail, Caila B. Vaughn, Haris Kamal, Robert N. Sawyer, and Christopher Deline, “Intravenous Thrombolysis for Stroke in Patients Receiving Oral Factor Xa Inhibitors,” ARCHIVES OF NEUROSCIENCE, vol. 5, no. 4, pp. 0–0, 2018, [Online]. Available: https://sid.ir/paper/354669/en

    Related Journal Papers

  • No record.
  • Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button